A 13-month complaint history review and service history review for similar complaints was performed for serial number (b)(4) from 14-feb-2017 through aware date 15-mar-2018.There were no similar complaints identified during the searched period.The g8 variant analysis mode operator's manual under chapter 1, introduction and applications, states the following: columns are warranted for 2500 injections.1.8 limitations of the procedure total area dilution studies demonstrate that the assay is linear from a total area of 500 to 4000.However, the optimum total area is 700 to 3000.Interpretation of results will not be reported if the total area (ta) is <500 which can be seen in severe anemia.Results will not be reported if the ta is >4000 which can be seen in polycythemia.(see "abnormal red cell survival in previous section).The optimal goal for total area is between 700-3000.However a ta in the range of 500-4000 is acceptable and reportable for whole blood specimens.The most probable cause of the reported event was due to an old column.Additional manufacturer narrative: (b)(4).
|
On (b)(6) 2018, a customer reported getting low total areas (optimal range 700-3000) while running patient samples on the g8 instrument.The technical support specialist (tss) instructed the customer to run a sample without the cap and one with the cap on; the sample without the cap had a normal total area, but the sample with the cap had a low total area.The tss advised the customer to replace the sampling needle assembly.The customer did not have a replacement sampling needle assembly, but could run patient samples with the caps on.The customer called back and reported that patient samples being run without the caps also had low total areas.The customer sent chromatograms for review, which showed high baseline on those patient samples.The customer reported that the column was 8036 (maximum recommended is 2500 injection counts).The tss advised the customer to replace the column.A new column was sent to the customer in order to resolve the reported issue, which resulted in delay in reporting of patient results for hemoglobin a1c (hba1c).There is no indication of any patient intervention or adverse health consequences due to the delay in reporting of patient results.On (b)(6) 2018, the customer reported that after replacing the column there were no issues with low total areas or high baselines on chromatograms.Quality controls were within acceptable range as well.
|